MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 255 filers reported holding MYRIAD GENETICS INC in Q2 2016. The put-call ratio across all filers is 3.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,535,000 | -70.6% | 44,726 | -69.0% | 0.10% | +472.2% |
| Q3 2017 | $5,225,000 | -35.7% | 144,412 | -54.1% | 0.02% | -33.3% |
| Q2 2017 | $8,131,000 | +1927.7% | 314,662 | +1405.6% | 0.03% | +2600.0% |
| Q1 2017 | $401,000 | +15.2% | 20,899 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $348,000 | -15.5% | 20,899 | +4.3% | 0.00% | 0.0% |
| Q3 2016 | $412,000 | -29.5% | 20,030 | +4.9% | 0.00% | -50.0% |
| Q2 2016 | $584,000 | – | 19,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |